Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Wave Life Sciences Ltd. (WVE)

$3.18 -5.07% NASDAQ: WVE · 15-min delayed
  • SINGAPORE, U0
  • Public · NASDAQ: WVE
  • 317 employees
$1.1BMarket cap
$42.7MRevenue · FY2025
-$204.4MNet income
317Employees
WVENASDAQ
2015IPO

About Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$42.7M
Net income
-$204.4M
Total assets
$638.5M
Market cap
$1.1B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: WVE
$3.18 -5.07%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.09 $21.31

52-week range

Market cap
$1.1B
Shares outstanding
351.5M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Nov 11, 2015

Wave Life Sciences Ltd. (WVE) Stock Price

  • Reported a net loss of $204.4M in FY2025.
  • Trading 85% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Wave Life Sciences Ltd..

Write a review
Newsroom

News about Wave Life Sciences Ltd.

News & sentiment via Polygon.io

FAQ

Wave Life Sciences Ltd.: frequently asked questions

Is Wave Life Sciences Ltd. an American company?

Wave Life Sciences Ltd. is a US-based company headquartered in Singapore, U0, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Wave Life Sciences Ltd. headquartered?

Wave Life Sciences Ltd. is headquartered in Singapore, U0, United States.

Is Wave Life Sciences Ltd. publicly traded?

Yes — Wave Life Sciences Ltd. is a publicly traded company. Its stock trades under the ticker symbol WVE on the NASDAQ.

What does Wave Life Sciences Ltd. do?

Wave Life Sciences Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →